53044 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 12
19:17 UTC
|
CJT
Cargojet
|
◎ Target | firm only | Outperform | C$110.00→ C$120.00+9.1% |
|
Aug 12
19:17 UTC
|
CJT
Cargojet
|
◎ Target | firm only | Buy | C$126.00→ C$135.00+7.1% |
|
Aug 12
19:17 UTC
|
CJT
Cargojet
|
◎ Target | firm only | Sec→ r Outperform | C$120.00→ C$125.00+4.2% |
|
Aug 12
19:17 UTC
|
CJT
Cargojet
|
◎ Target | firm only | Buy | C$118.00→ C$127.00+7.6% |
|
Aug 12
19:17 UTC
|
CJT
Cargojet
|
◎ Target | firm only | C$85.00→ C$90.00+5.9% | |
|
Aug 12
19:17 UTC
|
CGX
Cineplex
|
◎ Target | firm only | Sec→ r Outperform | C$12.00→ C$13.50+12.5% |
|
Aug 12
19:17 UTC
|
CGX
Cineplex
|
◎ Target | firm only | Outperform | C$13.00→ C$14.00+7.7% |
|
Aug 12
19:17 UTC
|
CGX
Cineplex
|
◎ Target | firm only | Outperform | C$13.50→ C$14.00+3.7% |
|
Aug 12
19:17 UTC
|
CDNL
Cardinal Infrastructure Group
|
◎ Target | Brian Brophy ★☆☆☆☆ #3039 | Buy | $63.00→ $52.00-17.5% |
|
Aug 12
19:17 UTC
|
CCAP
Crescent Capital BDC
|
◎ Target | Christopher Nolan ★★☆☆☆ #2697 | Buy | $15.00→ $14.00-6.7% |
|
Aug 12
19:17 UTC
|
CAH
Cardinal Health
|
◎ Target | Daniel Grosslight ★★★☆☆ #1225 | Buy | $265.00→ $280.00+5.7% |
|
Aug 12
19:17 UTC
|
BNS
Bank of Nova Scotia
|
◎ Target | firm only | Hold | C$113.00→ C$124.00+9.7% |
|
Aug 12
19:17 UTC
|
BNS
Bank of Nova Scotia
|
◎ Target | firm only | Outperform | C$121.00→ C$137.00+13.2% |
|
Aug 12
19:17 UTC
|
BMO
Bank of Montreal
|
◎ Target | firm only | Outperform | C$233.50→ C$268.00+14.8% |
|
Aug 12
19:17 UTC
|
BMO
Bank of Montreal
|
◎ Target | firm only | Buy | C$239.00→ C$263.00+10.0% |
|
Aug 12
19:17 UTC
|
BHST
BioHarvest Sciences
|
◎ Target | Anthony Vendetti ★☆☆☆☆ #3194 | Buy | $12.00→ $5.00-58.3% |
|
Aug 12
19:17 UTC
|
BCAX
Bicara Therapeutics
|
◎ Target | Richard Law not yet tracked | Neutral | $18.00→ $20.00+11.1% |
|
Aug 12
19:17 UTC
|
ARMK
Aramark
|
◎ Target | Stephanie Moore ★★☆☆☆ #2456 | Buy | $62.00→ $70.00+12.9% |
|
Aug 12
19:17 UTC
|
ARMK
Aramark
|
◎ Target | Shlomo Rosenbaum ★★★★★ #153 | Buy | $54.00→ $70.00+29.6% |
|
Aug 12
19:17 UTC
|
ANF
Abercrombie & Fitch
|
◎ Target | Corey Tarlowe ★★★★☆ #623 | Buy | $110.00→ $135.00+22.7% |
|
Aug 12
19:17 UTC
|
ALS
Altius Minerals
|
◎ Target | firm only | Outperform | C$70.00→ C$75.00+7.1% |
|
Aug 12
19:17 UTC
|
ACM
AECOM
|
◎ Target | Andrew Kaplowitz ★★★☆☆ #1130 | Buy | $97.00→ $84.00-13.4% |
|
Aug 12
19:17 UTC
|
AC
Air Canada
|
◎ Target | firm only | Outperform | C$30.00→ C$37.00+23.3% |
|
Aug 12
19:17 UTC
|
PET
Pet Valu
|
↓ Downgrade | firm only | Outperform→ Market Perform | C$21.00→ C$23.00+9.5% |
|
Aug 12
19:17 UTC
|
LEGN
Legend Biotech
|
↓ Downgrade | Trevor Allred ★★★★☆ #465 | Outperform→ Market Perform | $75.00→ $40.00-46.7% |
|
Aug 12
19:17 UTC
|
SMMT
Summit Therapeutics
|
↑ Upgrade | Daina Graybosch ★★★☆☆ #1553 | Underperform→ Market Perform | $12.00→ $13.00+8.3% |
|
Aug 12
18:17 UTC
|
WMB
Williams Companies
|
◎ Target | Gabe Daoud not yet tracked | Buy | $84.00→ $88.00+4.8% |
|
Aug 12
18:17 UTC
|
TOST
Toast
|
◎ Target | Matthew Coad ★★★★★ #286 | Buy | $33.00→ $39.00+18.2% |
|
Aug 12
18:17 UTC
|
SOFI
SoFi Technologies
|
◎ Target | Matthew Coad ★★★★★ #286 | Hold | $18.00→ $19.00+5.6% |
|
Aug 12
18:17 UTC
|
REPX
Riley Exploration Permian
|
◎ Target | Gabe Daoud not yet tracked | Buy | $47.00→ $41.00-12.8% |
|
Aug 12
18:17 UTC
|
RDCM
Radcom
|
◎ Target | Ryan Koontz ★☆☆☆☆ #3077 | Buy | $18.00→ $14.00-22.2% |
|
Aug 12
18:17 UTC
|
RAPP
Rapport Therapeutics
|
◎ Target | Douglas Tsao ★★★☆☆ #1643 | Buy | $40.00→ $66.00+65.0% |
|
Aug 12
18:17 UTC
|
KNTK
Kinetik
|
◎ Target | Gabe Daoud not yet tracked | Buy | $53.00→ $59.00+11.3% |
|
Aug 12
18:17 UTC
|
JRVR
James River Group
|
◎ Target | Mark Hughes ★★★★☆ #809 | Hold | $6.00→ $5.00-16.7% |
|
Aug 12
18:17 UTC
|
IMNM
Immunome
|
◎ Target | Supawat Thongthip not yet tracked | Buy | $37.00→ $38.00+2.7% |
|
Aug 12
18:17 UTC
|
EVH
Evolent Health
|
◎ Target | Jailendra Singh ★★★★★ #262 | Hold | $7.00→ $6.00-14.3% |
|
Aug 12
18:17 UTC
|
ET
Energy Transfer
|
◎ Target | Gabe Daoud not yet tracked | Buy | $23.00→ $25.00+8.7% |
|
Aug 12
18:17 UTC
|
DEC
Diversified Energy
|
◎ Target | Gabe Daoud not yet tracked | Buy | $17.00→ $20.00+17.6% |
|
Aug 12
18:17 UTC
|
CRWV
CoreWeave
|
◎ Target | Arvind Ramnani ★★★☆☆ #2155 | Buy | $126.00→ $155.00+23.0% |
|
Aug 12
18:17 UTC
|
CCJ
Cameco
|
◎ Target | Christopher Souther not yet tracked | Buy | $129.00→ $130.00+0.8% |
|
Aug 12
18:17 UTC
|
BWAY
Brainsway
|
◎ Target | Sam Eiber ★★★☆☆ #1950 | Buy | $18.00→ $20.00+11.1% |
|
Aug 12
18:17 UTC
|
BHST
BioHarvest Sciences
|
◎ Target | Sean McGowan ★☆☆☆☆ #2954 | Buy | $10.00→ $8.00-20.0% |
|
Aug 12
18:17 UTC
|
BBIO
BridgeBio Pharma
|
◎ Target | Danielle Brill ★★★☆☆ #2088 | Buy | $102.00→ $107.00+4.9% |
|
Aug 12
18:17 UTC
|
GAP
GAP
|
↓ Downgrade | Corey Tarlowe ★★★★☆ #623 | Buy→ Hold | $29.00→ $23.00-20.7% |
|
Aug 12
17:17 UTC
|
ZURA
Zura Bio
|
◎ Target | Martin Fan ★★☆☆☆ #2365 | Outperform | $15.00→ $22.00+46.7% |
|
Aug 12
17:17 UTC
|
USFD
US Foods
|
◎ Target | Brian Mullan ★★☆☆☆ #2523 | Neutral | $88.00→ $108.00+22.7% |
|
Aug 12
17:17 UTC
|
UPWK
Upwork
|
◎ Target | Maria Ripps ★★★☆☆ #1056 | Hold | $10.00→ $9.00-10.0% |
|
Aug 12
17:17 UTC
|
TXG
10x Genomics
|
◎ Target | Mason Carrico ★★★☆☆ #1698 | Overweight | $50.00→ $65.00+30.0% |
|
Aug 12
17:17 UTC
|
TWFG
TWFG
|
◎ Target | Tommy McJoynt not yet tracked | Market Perform | $26.00→ $29.00+11.5% |
|
Aug 12
17:17 UTC
|
RPD
Rapid7
|
◎ Target | Anne Meisner not yet tracked | Neutral | $7.00→ $15.00+114.3% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.